Discover
QNTM
Quantum BioPharma Ltd.
2.38
3 x 0.50
1 x 2.42
bid
ask
-
0.06
2.46%
2 @ 04:00 PM
2.38 +0.00 (0.00%)
| Ytd | -67.40% | |
| 1y | -81.02% |
2.29
day range
2.47
2.07
52 week range
12.46
| Open | 2.45 | Prev Close | 2.44 | Low | 2.29 | High | 2.47 | Mkt Cap | 15.30M |
| Vol | 76.74K | Avg Vol | 211.08K | EPS | -4.98 | P/E | N/A | Forward P/E | -0.41 |
| Beta | N/A | Short Ratio | 0.09 | Inst. Own | 16.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 3.14 | 200-d Avg | 3.90 | 1yr Est | 169.00 |
| Income Statement | |||
| Operating Expenses | 2.41M | ||
| Research and Development Expense | 387.43K | ||
| Selling, General and Administrative Expense | 1.76M | ||
| Operating Income | -2.41M | ||
| Interest Expense | 127.08K | ||
| Net Income | -3.25M | ||
| Net Income Common Stock | -3.25M | ||
| Net Income Common Stock (USD) | -2.29M | ||
| Consolidated Income | -3.09M | ||
| Net Income to Non-Controlling Interests | 160.03K | ||
| Earnings per Basic Share | -0.47 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.47 | ||
| Earning Before Interest & Taxes (EBIT) | -3.13M | ||
| Earning Before Interest & Taxes (USD) | -2.20M | ||
| Weighted Average Shares | 6.65M | ||
| Weighted Average Shares Diluted | 6.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.65M | ||
| Cash and Equivalents (USD) | 2.57M | ||
| Investments | 6.10M | ||
| Investments Current | 6.10M | ||
| Trade and Non-Trade Receivables | 107.63K | ||
| Current Assets | 9.96M | ||
| Property, Plant & Equipment Net | 125.89K | ||
| Total Assets | 14.39M | ||
| Debt Current | 963.31K | ||
| Total Debt | 963.31K | ||
| Current Liabilities | 8.30M | ||
| Total Liabilities | 8.30M | ||
| Accumulated Retained Earnings (Deficit) | -215.10M | ||
| Accumulated Other Comprehensive Income | 269.80K | ||
| Shareholders Equity | 7.95M | ||
| Shareholders Equity (USD) | 5.60M | ||
| Assets Non-Current | 4.43M | ||
| Total Debt (USD) | 678.39K | ||
| Goodwill and Intangible Assets | 4.30M | ||
| Inventory | 53.01K | ||
| Trade and Non-Trade Payables | 3.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 128.37K | ||
| Net Cash Flow from Financing | 2.46M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -694.84K | ||
| Issuance (Purchase) of Equity Shares | 2.48M | ||
| Issuance (Repayment) of Debt Securities | -21.57K | ||
| Net Cash Flow from Investing | -1.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.36M | ||
| Net Cash Flow from Operations | -1.79M | ||
| Share Based Compensation | 13.45K | ||